Seaport Therapeutics, Inc. Common Stock (SPTX) — Financial Flexibility Index

Latest as of June 2026: -1.37x

Seaport Therapeutics, Inc. Common Stock (SPTX) has a Financial Flexibility Index of -1.37x as of June 2026. Free cash flow of $-26.14 Million (operating CF $-26.14 Million minus capex $0.00) represents -1% of total liabilities ($19.08 Million). Check how tangible is Seaport Therapeutics, Inc. Common Stock's equity to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-1.37x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-26.14 Million
Operating CF − Capex

Total Liabilities

$19.08 Million
USD

Capital Expenditures

$0.00
USD

Seaport Therapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)

Historical Financial Flexibility Index trend for Seaport Therapeutics, Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see SPTX operating cash flow.

Annual Financial Flexibility Index for Seaport Therapeutics, Inc. Common Stock (2024–2025)

Year-by-year free cash flow to debt coverage for Seaport Therapeutics, Inc. Common Stock. Explore how well can Seaport Therapeutics, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.23x $-77.59 Million $-77.94 Million $341.55 Million ▼ -162.1%
2024 -0.09x $-29.52 Million $-29.63 Million $340.63 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities